Download PDF
Arzneimittelforschung 2010; 60(8): 492-496
DOI: 10.1055/s-0031-1296317
Analgesics · Anti-inflammatories · Antiphlogistics · Antirheumatic Drugs
Editio Cantor Verlag Aulendorf (Germany)

Synthesis and analgesic effects of 1-[1-(2-methylphenyl)(cyclohexyl)]-3-piperidinol as a new derivative of phencyclidine in mice

Abbas Ahmadi
1   Department of Chemistry, Faculty of Science, Islamic Azad University, Karaj branch, Karaj, Iran
,
Jalal Solati
2   Department of Physiology, Islamic Azad University, Karaj Branch, Karaj, Iran
,
Ramin Hajikhani
2   Department of Physiology, Islamic Azad University, Karaj Branch, Karaj, Iran
,
Masoud Onagh
1   Department of Chemistry, Faculty of Science, Islamic Azad University, Karaj branch, Karaj, Iran
,
Mojdeh Javadi
1   Department of Chemistry, Faculty of Science, Islamic Azad University, Karaj branch, Karaj, Iran
› Author Affiliations
Further Information

Publication History

Publication Date:
03 December 2011 (online)

    Permissions and Reprints

Abstract

Phencyclidine (1-(1-phenylcyclohexyl) piperidine, CAS 956-90-1, PCP, I) and its derivatives have shown many analgesic effects. In this research, a new derivative of PCP (1-[1-(2-methylphenyl)(cyclohexyl)]-3-piperidinol, PD, II) was synthesized and its analgesic (acute and chronic pains) effects were examined on rats using tail immersion (as a model of acute thermal pain) and formalin (as a model of acute and chronic chemical pain) tests and the results are compared to PCP and control groups.

The results indicated that II produces higher analgesic effects in the tail immersion test compared to the PCP and control groups, with a marked and significant increase in tail immersion latency for the doses 1, 5 and 10 mg/kg. The formalin test showed that PD (II) is not effective in acute chemical pain (phase I, 0–5 min after injection) in all doses but chronic pain (initial-phase II, 15–40 min after injection) is significantly attenuated by this compound compared to PCP and saline (control) in doses of 5 and 10 mg/kg.

It is concluded that II is effective in acute thermal (in all doses) and chronic (doses of 5 and 10 mg/kg) pains; however, it is not effective in acute chemical pain compared to PCP and control.

Key words

Acute and chronic pain - Analgesics - CAS 956-90-1 - Formalin test - Phencyclidine, derivative - Tail immersion test
 

  • References

  • 1 Sattlegger M, Reissmüller E inventors; Grünenthal GmbH Aachen (DE), assignee. Substituted dimethyl-[1-(1-phenyl-cyclohexyl)-piperidin-3-ylmethyl]amines and the use of the same as analgesics. United States patent US 2004 0127516 A1. 2004.
    PubMed
  • 2 Kamenka JM, Chiche B, Goudal R, Geneste P, Vignon J, Vincent JP et al. Chemical synthesis and molecular pharmacology of hydroxylated 1-[1-phenylcyclohexyl]piperi-dine derivatives. J Med Chem. 1982; 25: 431-5
    CrossrefPubMedGoogle Scholar
  • 3 Al-deeb OA.. Synthesis and analgesic activity of new phencyclidine derivatives. Arzneimittelforschung. 1994; 44 (10) 1141-4
    PubMedGoogle Scholar
  • 4 Ahmadi A, Mahmoudi A. Synthesis and biological properties of 2-hydroxy-1-(1-phenyltetralyl)piperidine and some of its intermediates as derivatives of phencyclidine. Arzneimittelforschung. 2005; 55 (9) 528-32
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Al-deeb OA. New analgesics derived from the phencyclidine analogue thienylcyclidine. Arzneimittelforschung. 1996; 46 ((I)) 505-508
    PubMedGoogle Scholar
  • 6 Ahmadi A, Shafiezadeh M, Fathollahi Y, Darvich MR, Mahmoudi A, Bahmani M et al. Synthesis with improved yield and study on the analgesic effect of 2-hydroxyphencyclidine. Arzneimittelforschung. 2005; 55 (3) 172-6
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Geneste P, Kamenka JM, Ung MSN, Herrmann P, Goudal R, Trouiller G. Determination conformationnelle de derives de la phencyclidine en vue d’une correlation structure-active. Eur J Med Chem Ther. 1979; 14: 301-8 French
    PubMedGoogle Scholar
  • 8 Ahmadi A, Khalili M, Abbassi S, Javadi M, Mahmoudi A, Hajikhani R. Synthesis and study on analgesic effects of 1-[1-(4-methylphenyl)(cyclohexyl)]-4-piperidinol and 1-[1-(4-methoxyphenyl)[(cyclohexyl)]-4-piperidinol as two new phencyclidine derivatives. Arzneimittelforschung. 2009; 59 (4) 202-6
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Ahmadi A, Khalili M, Mihandoust F, Barghi L. Synthesis and determination of acute and chronic pain activities of 1-[1-(3-methyphenyl)(tetralyl)]piperidine as a new derivative of phencyclidine via tail immersion and formalin tests. Arzneimittelforschung. 2010; 60 (1) 30-5
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Medvedev IO, Malyshkin AA, Belozertseva IV, Sukhotina IA, Sevostianova NY, Aliev K et al. Effects of low-affinity NMDA receptor channel blockers in two rat models of chronic pain. Neuropharmacology. 2004; 47: 175-83
    CrossrefPubMedGoogle Scholar
  • 11 Honey CR, Miljkovic Z, MacDonald JF. Ketamine and phencyclidine cause a voltage-dependent block of responses to L-aspartic acid. Neurosci Lett. 1985; 61 ((1–2)) 135-9
    CrossrefPubMedGoogle Scholar
  • 12 Mozayani A. Phencyclidine – effects on human performance and behavior. Forensic Sci Rev. 2003; 15 (1) 62-74
    PubMedGoogle Scholar
  • 13 Dougherty PM, Staats PS. Intrathecal drug therapy for chronic pain: from basic science to clinical practice. Anesthesiolog. 1999; 91: 1891-918
    CrossrefPubMedGoogle Scholar
  • 14 Johnson PY, Pan R, QuanWen J, Halfman CJ. Synthesis of amine derivatives of phencyclidine. J Org Chem. 1981; 46: 2049-54
    CrossrefPubMedGoogle Scholar
  • 15 Shebley M, Jushchyshyn MI, Hollenberg F. Selective pathways for the metabolism of phencyclidine by cytochrome P450 2B enzymes: identification of electrophilic methabolites, glutathione and N-acetyl cysteine adducts. Drug Metab Disp. 2006; 34 (3) 375-383
    PubMedGoogle Scholar
  • 16 Maddox VH, Godefroi EF, Parcell RF. The synthesis of phencyclidine and other 1-arylcyclohexylamines. J Med Chem. 1965; 8: 230-5
    CrossrefPubMedGoogle Scholar
  • 17 Deleuze-Masquefa C, Michaud M, Vignon J, Kamenka JM. 1-[1-(2-Benzo[b]thiopheneyl]cyclohexyl]piperidine hydrochloride (BTCP) yields two active primary metabolites in vitro: synthesis, identification from rat liver microsome extracts affinity for the neuronal dopamine transporter. J Med Chem. 1997; 40: 4019-25
    CrossrefPubMedGoogle Scholar
  • 18 Hamura H, Yoshida M, Shimizu K, Matsukura T, Suzuki H, Narita M et al. Antinociceptive effect of the combination of pentazocine with morphine in the tail-immersion and scald-pain tests in rats. Jpn J Pharmacol. 2000; 83 (4) 286-92
    CrossrefPubMedGoogle Scholar
  • 19 Padi SSV, Kulkarni S. K. Minocycline prevents the development of neuropathic pain, but not acute pain: possible anti-inflammatory and antioxidant mechanisms. Eur J Pharmacol. 2008; 601: 79-87
    CrossrefPubMedGoogle Scholar
  • 20 Ibrahim MM, Rude ML, Stagg NJ, Mata HP, Lai J, Vanderah TW et al. CB2 cannabinoid receptor mediation of antinociception. Pain. 2006; 122: 36-42
    CrossrefPubMedGoogle Scholar
  • 21 Matthes HWD, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I et al. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ -opioid-receptor gene. Nature. 1996; 383: 819-23
    CrossrefPubMedGoogle Scholar
  • 22 Hunter JC, Fontana DJ, Hedley LR, Jasper JR, Lewis R, Link RE et al. Assessment of the role of a 2-adrenoceptor sub type in the antinociceptive, sedative and hypothermic action of dexmedetomidine in transgenic mice. Br J Pharmacol. 1997; 122: 1339-44
    CrossrefPubMedGoogle Scholar
  • 23 Dubuisson D, Dennis SG. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine and brain stem stimulation in rats and cats. Pain. 1977; 4 (2) 161-74
    CrossrefPubMedGoogle Scholar
  • 24 Moriarty RM, Enache LA, Zhao L, Gilardi R, Mattson MV, Prakash O. Rigid phencyclidine analogues: binding to the phencyclidine and sigma receptors. J Med Chem. 1998; 41: 468-77
    CrossrefPubMedGoogle Scholar
  • 25 Kamenka JM, Hamon J, Vignon J inventors; Societe de conseils de recherches et d’applications scientifiques (S.C.R.A.S.) (FR), assignee. Phencyclidine derivatives, preparation method and pharmaceutical compositions containing same. United States Patents US 6,342, 511B1. 2002
    PubMed
  • 26 Nicholson KL, Balster RL. Evaluation of the phencyclidine-like discriminative stimulus effects of novel NMDA channel blockers in rats. Psychopharmacology. 2003; 170: 215-24
    CrossrefPubMedGoogle Scholar